General practitioners' attitudes and behaviors toward HPV vaccination: A French national survey

Vaccine

Volumn 34, Issue 6, 2016, Pages 762-768

  Collange, Fanny ^a,b,c   Fressard, Lisa ^a,b,c   Pulcini, Céline ^d,e   Sebbah, Rémy ^f   Peretti Watel, Patrick ^a,b,c   Verger, Pierre ^a,b,c,g  

^a AIX MARSEILLE UNIVERSITY   (France)

^b AIX MARSEILLE UNIV   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d CHU NANCY BRABOIS   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f Self employed Physicians (URPS ML PACA)   (France)

^g INSERM   (France)

Author keywords

General practice; Health personnel attitudes; Papillomavirus vaccines; Risk perception; Vaccine hesitancy

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; FRANCE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT; VACCINATION; CLINICAL PRACTICE; FEMALE; HEALTH PERSONNEL ATTITUDE; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GENERAL PRACTITIONERS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRACTICE PATTERNS, PHYSICIANS'; SURVEYS AND QUESTIONNAIRES;

EID: 84958764942     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.12.054     Document Type: Article

References (50)

1. European Centre for Disease Prevention and Control Introduction of HPV Vaccines in European Union Countries - An Update 2012, ECDC, Stockholm.
2. Skinner S.R., Cooper Robbins S.C. Voluntary school-based human papillomavirus vaccination: an efficient and acceptable model for achieving high vaccine coverage in adolescents. J Adolesc Health 2010, 47:215-218. 10.1016/j.jadohealth.2010.07.002.
3. Institut de Veille Sanitaire. Dossier thématique: vaccin HPV 2015. [Accessed 12.12.15]. http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale/Donnees/Papillomavirus-humains.
4. CDC National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2014. Morb Mortal Wkly Rep 2015, 64:784-796.
5. Kessels S.J.M., Marshall H.S., Watson M., Braunack-Mayer A.J., Reuzel R., Tooher R.L. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012, 30:3546-3556. 10.1016/j.vaccine.2012.03.063.
6. Peretti-Watel P., Verger P., Raude J., Constant A., Gautier A., Jestin C., et al. Dramatic change in public attitudes towards vaccination during the 2009 influenza A(H1N1) pandemic in France. Eurosurveillance 2013, 18:20623. 10.2807/1560-7917.ES2013.18.44.20623.
7. Verger P., Fressard L., Collange F., Gautier A., Jestin C., Launay O., et al. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine 2015, 2:891-897. 10.1016/j.ebiom.2015.06.018.
8. Larson H.J., Jarrett C., Eckersberger E., Smith D.M.D., Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine 2014, 32:2150-2159. 10.1016/j.vaccine.2014.01.081.
9. WHO SAGE working group dealing with vaccine hesitancy (March 2012 to November 2014) 2012, http://www.who.int/immunization/sage/sage_wg_vaccine_hesitancy_apr12/en/ [accessed 12.12.15].
10. European Medecines Agency HPV vaccines: EMA confirms evidence does not support that they cause CRPS or POTS 2015, vol. 44. EMA, London.
11. Grimaldi-Bensouda L., Guillemot D., Godeau B., Bénichou J., Lebrun-Frenay C., Papeix C., et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med 2014, 275:398-408. 10.1111/joim.12155.
12. Scheller N.M., Svanström H., Pasternak B., Arnheim-dahlström L. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system. JAMA 2015, 313:54-61. 10.1001/jama.2014.16946.
13. Pétition pour la mise en place d'une mission parlementaire concernant le Gardasil-[Petition for the implementation of a parliamentary mission concerning Gardasil]. 2014. [Accessed 12.12.15]. http://www.medocean.re/new/actions/vaccin-gardasil/item/90-petition-pour-la-mise-en-place-d-une-mission-parlementaire-concernant-le-gardasil.
14. Holman D.M., Benard V., Roland K.B., Watson M., Liddon N., Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 2014, 168:76-82. 10.1001/jamapediatrics.2013.2752.
15. Haesebaert J., Lutringer-Magnin D., Kalecinski J., Barone G., Jacquard A-C., Régnier V., et al. French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14-18 year old daughters: a quantitative-qualitative study. BMC Public Health 2012, 12:1034. 10.1186/1471-2458-12-1034.
16. Lions C., Pulcini C., Verger P. Papillomavirus vaccine coverage and its determinants in South-Eastern France. Med Mal Infect 2013, 43:195-201. 10.1016/j.medmal.2013.03.003.
17. Ganry O., Bernin-Mereau A-S., Gignon M., Merlin-Brochard J., Schmit J-L. Human papillomavirus vaccines in Picardy, France: coverage and correlation with socioeconomic factors. Rev Epidemiol Sante Publique 2013, 61:447-454. 10.1016/j.respe.2013.04.005.
18. Hopkins T.G., Wood N. Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes. Vaccine 2013, 31:1673-1679. 10.1016/j.vaccine.2013.01.028.
19. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126:425-433. 10.1542/peds. 2009-3500.
20. Lasset C., Kalecinski J., Régnier V., Barone G., Leocmach Y., Vanhems P., et al. Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010. Int J Public Health 2014, 59:519-528. 10.1007/s00038-014-0555-9.
21. Vadaparampil S.T., Malo T.L., Kahn J.A., Salmon D.A., Lee J-H., Quinn G.P., et al. Physicians' human papillomavirus vaccine recommendations, 2009 and 2011. Am J Prev Med 2014, 46:80-84. 10.1016/j.amepre.2013.07.009.
22. McSherry L.A., Dombrowski S.U., Francis J.J., Murphy J., Martin C.M., O'Leary J.J., et al. Its a can of worms': understanding primary care practitioners' behaviours in relation to HPV using the Theoretical Domains Framework. Implement Sci 2012, 7:73. 10.1186/1748-5908-7-73.
23. Le Maréchal M., Collange F., Fressard L., Peretti-Watel P., Sebbah R., Mikol F., et al. Design of a national and regional survey among French general practitioners and method of the first wave of survey dedicated to vaccination. Med Mal Infect 2015, 45:403-410. 10.1016/j.medmal.2015.09.005.
24. Pulcini C., Massin S., Launay O., Verger P. Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey. Vaccine 2013, 31:3943-3949. 10.1016/j.vaccine.2013.06.039.
25. Bland J.M., Altman D.G. Statistics notes: Cronbach's alpha. BMJ 1997, 314. 572-572. 10.1136/bmj.314.7080.572.
26. Tavakol M., Dennick R. Making sense of Cronbach's alpha. Int J Med Educ 2011, 2:53-55. 10.5116/ijme.4dfb.8dfd.
27. Flicoteaux R., Pulcini C., Carrieri P., Schwarzinger M. Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns. Vaccine 2014, 32:2281-2287.
28. Turkheimer F.E., Hinz R., Cunningham V.J. On the undecidability among kinetic models: from model selection to model averaging. J Cereb Blood Flow Metab 2003, 23:490-498. 10.1097/01.WCB.0000050065.57184.BB.
29. Burnham K.K.P., Anderson D.R.D. Model selection and multimodel inference 2004, vol. 172. Springer, New York, NY. 10.1007/b97636.
30. Wright D.B., Hanoteau F., Parkinson C., Tatham A. Perceptions about memory reliability and honesty for children of 3 to 18 years old. Leg Criminol Psychol 2010, 15:195-207. 10.1348/135532508X400347.
31. Kass R.E., Raftery A.E., Bayes Factors J Am Stat Assoc 1995, 90:773-795. 10.1080/01621459.1995.10476572.
32. Posada D., Buckley T. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and Bayesian approaches over likelihood ratio tests. Syst Biol 2004, 53:793-808. 10.1080/10635150490522304.
33. Viallefont V., Raftery A.E., Richardson S. Variable selection and Bayesian model averaging in case-control studies. Stat Med 2001, 20:3215-3230. 10.1002/sim.976.
34. Lutringer-Magnin D., Kalecinski J., Barone G., Leocmach Y., Regnier V., Jacquard A.C., et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine 2011, 29:5322-5328. 10.1016/j.vaccine.2011.05.006.
35. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18:391-398. 10.1016/j.jpag.2005.09.004.
36. Bynum S.A., Staras S.A.S., Malo T.L., Giuliano A.R., Shenkman E., Vadaparampil S.T. Factors associated with medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health 2014, 54:190-196. 10.1016/j.jadohealth.2013.08.006.
37. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.-H., Quinn G.P., Roetzheim R., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011, 29:8634-8641. 10.1016/j.vaccine.2011.09.006.
38. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007, 161:252-259. 10.1001/archpedi.161.3.252.
39. Bruno D.M., Wilson T.E., Gany F., Aragones A. Identifying human papillomavirus vaccination practices among primary care providers of minority, low-income and immigrant patient populations. Vaccine 2014, 32:4149-4154. 10.1016/j.vaccine.2014.05.058.
40. Dubé E., Laberge C., Guay M., Bramadat P., Roy R., Bettinger J.A. Vaccine hesitancy. Hum Vaccin Immunother 2013, 9:1763-1773. 10.4161/hv.24657.
41. European Centre for Disease Prevention and Control Vaccine hesitancy among healthcare workers and their patients in Europe: a qualitative study 2015, ECDC, Stockholm.
42. Paraponaris A., Verger P., Desquins B., Villani P., Bouvenot G., Rochaix L., et al. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Heal Policy 2004, 70:23-32. 10.1016/j.healthpol.2004.01.008.
43. Peretti-Watel P., Ward J.K., Schulz W.S., Verger P., Larson H.J. Vaccine hesitancy clarifying a theoretical framework for an ambiguous notion. PLOS Curr Outbreaks 2015, 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289.
44. Peretti-Watel P., Raude J., Sagaon-Teyssier L., Constant A., Verger P., Beck F. Attitudes toward vaccination and the H1N1 vaccine: poor people's unfounded fears or legitimate concerns of the elite?. Soc Sci Med 2014, 109:10-18. 10.1016/j.socscimed.2014.02.035.
45. Joyce C.M., Scott A., Jeon S-H., Humphreys J., Kalb G., Witt J., et al. The medicine in Australia: balancing employment and life (MABEL) longitudinal survey-protocol and baseline data for a prospective cohort study of Australian doctors' workforce participation. BMC Health Serv Res 2010, 10:50. 10.1186/1472-6963-10-50.
46. Brien S., Kwong J.C., Buckeridge D.L. The determinants of 2009 pandemic A/H1N1 influenza vaccination: a systematic review. Vaccine 2012, 30:1255-1264. 10.1016/j.vaccine.2011.12.089.
47. Llupià A., García-Basteiro A.L., Mena G., Ríos J., Puig J., Bayas J.M., et al. Vaccination behaviour influences self-report of influenza vaccination status: a cross-sectional study among health care workers. PLoS ONE 2012, 7:e39496. 10.1371/journal.pone.0039496.
48. Henrikson N.B., Opel D.J., Grothaus L., Nelson J., Scrol A., Dunn J., et al. Physician communication training and parental vaccine hesitancy: a randomized trial. Pediatrics 2015, 136:70-79. 10.1542/peds. 2014-3199.
49. Eskola J., Duclos P., Schuster M., MacDonald N.E. How to deal with vaccine hesitancy?. Vaccine 2015, 33:4215-4217. 10.1016/j.vaccine.2015.04.043.
50. Dubé E., Gagnon D., MacDonald N.E. Strategies intended to address vaccine hesitancy: review of published reviews. Vaccine 2015, 33:4191-4203. 10.1016/j.vaccine.2015.04.041.